HIMS & HERS HEALTH INC (HIMS) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
37.21 USD
-0.56 (-1.48%)
37.21 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 526.916M 93.81% | 872M 65.49% | 1.477B 69.33% | 2.395B 62.21% | 2.845B 18.79% | 3.401B 19.54% | 3.528B 3.73% | 3.89B 10.26% | 4.261B 9.54% | 4.585B 7.60% | 5.027B 9.64% | |
| EBITDA YoY % growth | -58.904M 39.67% | -16.493M 72.00% | 85.092M 615.93% | 319.6M 275.59% | 386.05M 20.79% | 491.42M 27.29% | 579.73M 17.97% | 705.42M 21.68% | 824.29M 16.85% | 850.24M 3.15% | 969.02M 13.97% | |
| EBIT YoY % growth | -66.378M 34.74% | -26.008M 60.82% | 68.004M 361.47% | 116.49M 71.30% | 180.47M 54.92% | 225.17M 24.77% | 401.84M 78.46% | 540.88M 34.60% | 670.34M 23.94% | 716.18M 6.84% | 834.27M 16.49% | |
| Operating Margin | -12.60% | -2.98% | 4.61% | 4.86% | 6.34% | 6.62% | 11.39% | 13.90% | 15.73% | 15.62% | 16.60% | |
| EPS YoY % growth | -0.32 42.75% | -0.11 65.63% | 0.54 590.91% | 0.49 -9.33% | 0.66 34.66% | 0.84 28.10% | 2.41 185.02% | 3.09 28.39% | 3.97 28.38% | 5.10 28.53% | 6.55 28.40% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.05 -58.79% | 0.16 -18.40% | 0.17 -2.00% | 0.20 237.16% | 0.27 496.31% | 0.32 93.75% | 0.44 163.27% | 0.19 -4.20% | 0.26 -5.66% |
| Revenue Q2Q % growth | 631.64M 31.28% | 665.11M 13.50% | 671.98M 23.34% | 728.96M 21.70% | 769.05M 21.75% | 771.07M 15.93% | 761.82M 13.37% | 784.66M 7.64% | 854.56M 11.12% |
| EBITDA Q2Q % growth | 63.932M 60.44% | 86.588M 30.80% | 88.651M 71.49% | 100.54M 84.19% | 115.66M 80.91% | 132.9M 53.49% | 143.61M 61.99% | 128.61M 27.92% | 143.02M 23.66% |
| EBIT Q2Q % growth | 13.702M -39.80% | 42.637M -26.39% | 47.65M 44.60% | 59.645M 228.15% | 74.902M 446.65% | 61.2M 43.54% | 86.496M 81.52% | 35.292M -40.83% | 47.838M -36.13% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.06 -81.25% | 0.11 | -0.05 | -43.53% |
| Q2 2025 Q2Q % growth | 0.17 183.33% | 0.15 | 0.02 | 10.29% |
| Q1 2025 Q2Q % growth | 0.20 300.00% | 0.12 | 0.08 | 62.17% |
| Q4 2024 Q2Q % growth | 0.11 1,000.00% | 0.11 | 0.00 | 4.62% |
| Q3 2024 Q2Q % growth | 0.32 900.00% | 0.04 | 0.28 | 666.87% |
| Q2 2024 Q2Q % growth | 0.06 300.00% | 0.04 | 0.02 | 37.66% |
| Q1 2024 Q2Q % growth | 0.05 200.00% | 0.01 | 0.04 | 308.50% |
| Q4 2023 Q2Q % growth | 0.01 120.00% | -0.02 | 0.03 | 152.29% |
| Q3 2023 Q2Q % growth | -0.04 55.56% | -0.03 | -0.01 | -24.77% |
| Q2 2023 Q2Q % growth | -0.03 70.00% | -0.06 | 0.03 | 45.82% |
| Q1 2023 Q2Q % growth | -0.05 37.50% | -0.07 | 0.02 | 31.37% |
| Q4 2022 Q2Q % growth | -0.05 66.67% | -0.07 | 0.02 | 26.47% |
| Q3 2022 Q2Q % growth | -0.09 -13.92% | -0.10 | 0.01 | 13.49% |
| Q2 2022 Q2Q % growth | -0.10 -233.33% | -0.10 | 0.00 | 3.57% |
| Q1 2022 Q2Q % growth | -0.08 73.33% | -0.07 | -0.01 | -10.08% |
| Q4 2021 Q2Q % growth | -0.15 -114.29% | -0.07 | -0.08 | -102.84% |
| Q3 2021 Q2Q % growth | -0.08 | -0.06 | -0.02 | -25.59% |
| Q2 2021 Q2Q % growth | -0.03 | -0.08 | 0.05 | 64.24% |
| Q1 2021 Q2Q % growth | -0.30 | -0.11 | -0.19 | -180.78% |
| Q4 2020 Q2Q % growth | -0.07 | -0.16 | 0.09 | 57.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 598.976M 49.16% | 591.85M | 7.126M | 1.20% |
| Q2 2025 Q2Q % growth | 544.833M 72.61% | 562.65M | -17.817M | -3.17% |
| Q1 2025 Q2Q % growth | 586.01M 110.67% | 548.97M | 37.04M | 6.75% |
| Q4 2024 Q2Q % growth | 481.139M 95.45% | 479.72M | 1.419M | 0.30% |
| Q3 2024 Q2Q % growth | 401.556M 77.13% | 389.85M | 11.706M | 3.00% |
| Q2 2024 Q2Q % growth | 315.648M 51.82% | 305.94M | 9.708M | 3.17% |
| Q1 2024 Q2Q % growth | 278.171M 45.81% | 275.79M | 2.381M | 0.86% |
| Q4 2023 Q2Q % growth | 246.169M 47.23% | 251.38M | -5.211M | -2.07% |
| Q3 2023 Q2Q % growth | 226.699M 56.52% | 224.45M | 2.249M | 1.00% |
| Q2 2023 Q2Q % growth | 207.912M 83.08% | 209.06M | -1.148M | -0.55% |
| Q1 2023 Q2Q % growth | 190.77M 88.30% | 182.66M | 8.11M | 4.44% |
| Q4 2022 Q2Q % growth | 167.203M 97.41% | 164.39M | 2.813M | 1.71% |
| Q3 2022 Q2Q % growth | 144.836M 95.27% | 132.95M | 11.886M | 8.94% |
| Q2 2022 Q2Q % growth | 113.563M 87.11% | 105.96M | 7.603M | 7.18% |
| Q1 2022 Q2Q % growth | 101.314M 93.67% | 92.998M | 8.316M | 8.94% |
| Q4 2021 Q2Q % growth | 84.699M | 78.329M | 6.37M | 8.13% |
| Q3 2021 Q2Q % growth | 74.173M | 71.942M | 2.231M | 3.10% |
| Q2 2021 Q2Q % growth | 60.692M | 57.623M | 3.069M | 5.33% |
| Q1 2021 Q2Q % growth | 52.314M | 49.79M | 2.524M | 5.07% |
| Q4 2020 Q2Q % growth | 37.744M | -37.744M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -32.49% | -66.29% | -18.96% | -18.37% |
| Revenue | 0.02% | -1.91% | 0.29% | 0.25% |